These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7521963)

  • 21. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple screening for fetal Down's syndrome with the classic triple test, dimeric inhibin A and ultrasound.
    Debiève F; Bouckaert A; Hubinont C; Thomas K
    Gynecol Obstet Invest; 2000; 49(4):221-6. PubMed ID: 10828702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-trimester dimeric inhibin-A in Down's syndrome screening.
    Spencer K; Wallace EM; Ritoe S
    Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
    Wald NJ; Cuckle HS; Densem JW; Stone RB
    Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald N; Cuckle H; Wu TS; George L
    Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
    Canick JA; Knight GJ; Palomaki GE; Haddow JE; Cuckle HS; Wald NJ
    Br J Obstet Gynaecol; 1988 Apr; 95(4):330-3. PubMed ID: 2968116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.
    Wald NJ; White N; Morris JK; Huttly WJ; Canick JA
    Br J Obstet Gynaecol; 1999 Dec; 106(12):1304-6. PubMed ID: 10609726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Down's syndrome.
    Chard T
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):15. PubMed ID: 8706287
    [No Abstract]   [Full Text] [Related]  

  • 31. Four-marker serum screening for Down's syndrome.
    Wald NJ; Densem JW; Smith D; Klee GG
    Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies.
    Wenstrom KD; Owen J; Chu DC; Boots L
    Am J Obstet Gynecol; 1997 Nov; 177(5):992-6. PubMed ID: 9396881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal serum markers for Down's syndrome pregnancies.
    Chew S; Anandakumar C; Ratnam SS
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
    Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparently low maternal serum inhibin A levels in second-trimester screening.
    Lambert-Messerlian GM; Keren DF; Raphtis CS; Byberg K; Canick JA
    Prenat Diagn; 2005 Oct; 25(10):967-8. PubMed ID: 16193465
    [No Abstract]   [Full Text] [Related]  

  • 37. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome.
    Van Lith JM; Pratt JJ; Beekhuis JR; Mantingh A
    Prenat Diagn; 1992 Oct; 12(10):801-6. PubMed ID: 1475248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Wallace EM; Swanston IA; McNeilly AS; Ashby JP; Blundell G; Calder AA; Groome NP
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):17-21. PubMed ID: 8706288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.